Becker's Healthcare October 6, 2023
Jakob Emerson

Walmart is experiencing less food demand from individuals taking GLP-1s such as Ozempic or Wegovy, Bloomberg reported Oct. 4.

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” Walmart U.S. CEO John Furner told the publication. “Just less units, slightly less calories.”

According to the report, Walmart and some food manufacturers are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Retailer
AI, Omnichannel and Social Commerce: Inside the 2024 D2C Transformation
How AI Is Quietly Transforming E-Commerce Search And Discovery
Walmart's '24 healthcare exit: 10 notes
What big retailers did in healthcare in 2024
How Trauma-Informed Design Principles Can Be Health-Ful for All of Us – Learning from IKEA

Share This Article